Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Bull World Health Organ ; 87(4): 279-87, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19551236

ABSTRACT

OBJECTIVE: To assess the extent to which user fees for antiretroviral therapy (ART) represent a financial barrier to access to ART among HIV-positive patients in Yaoundé, Cameroon. METHODS: Sociodemographic, economic and clinical data were collected from a random sample of 707 HIV-positive patients followed up in six public hospitals of the capital city (Yaoundé) and its surroundings through face-to-face interviews carried out by trained interviewers independently from medical staff and medical questionnaires filled out by prescribing physicians. Logistic regression models were used to identify factors associated with self-reported financial difficulties in purchasing ART during the previous 3 months. FINDINGS: Of the 532 patients treated with ART at the time of the survey, 20% reported financial difficulty in purchasing their antiretroviral drugs during the previous 3 months. After adjustment for socioeconomic and clinical factors, reports of financial difficulties were significantly associated with lower adherence to ART (odds ratio, OR: 0.24; 95% confidence interval, CI: 0.15-0.40; P < 0.0001) and with lower CD4+ lymphocyte (CD4) counts after 6 months of treatment (OR: 2.14; 95% CI: 1.15-3.96 for CD4 counts < 200 cells/microl; P = 0.04). CONCLUSION: Removing a financial barrier to treatment with ART by eliminating user fees at the point of care delivery, as recommended by WHO, could lead to increased adherence to ART and to improved clinical results. New health financing mechanisms based on the public resources of national governments and international donors are needed to attain universal access to drugs and treatment for HIV infection.


Subject(s)
Anti-Retroviral Agents/economics , HIV Infections/economics , Health Expenditures , Adult , Anti-Retroviral Agents/therapeutic use , Cameroon , Cost Sharing , Cross-Sectional Studies , Female , HIV Infections/drug therapy , Health Services Accessibility/economics , Humans , Male
2.
Soc Sci Med ; 69(6): 885-91, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19560244

ABSTRACT

Encouraging seropositive people to voluntarily disclose their serostatus has been promoted as a key component of HIV prevention. Among other reasons, HIV disclosure to one's main partner is believed to be an incentive for serodiscordant couples to practice safe sex. The present article investigated this issue by conducting a cross-sectional survey of a large sample of HIV-infected women attending HIV care centers in Cameroon (N=1014). Overall, 86.3% of these women had disclosed their serostatus to their main partner. With respect to sexual activity with their main partner during the previous three months, 35.0% had practiced abstinence and 47.4% only safe sex, whereas 17.6% had engaged in unsafe sex at least once. HIV disclosure to one's main partner was related to safe sexual practices in multivariate analysis. Some of the factors associated with disclosure and safe sex were illustrative of the positive roles of improved access to care and women's empowerment. On the contrary, beliefs overestimating the effectiveness of antiretroviral therapies were quite widespread among respondents and predictive of both concealment of HIV status and unsafe sex.


Subject(s)
Disease Transmission, Infectious/prevention & control , HIV Infections/transmission , HIV Seropositivity/psychology , Self Disclosure , Unsafe Sex/psychology , Unsafe Sex/statistics & numerical data , Adult , Analysis of Variance , Cameroon , Cross-Sectional Studies , Female , Health Knowledge, Attitudes, Practice , Health Services Accessibility , Humans , Male , Multivariate Analysis , Power, Psychological , Safe Sex/psychology , Safe Sex/statistics & numerical data , Sexual Partners , Socioeconomic Factors , Surveys and Questionnaires
3.
Health Policy ; 92(2-3): 165-73, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19371960

ABSTRACT

CONTEXT: The national antiretroviral treatment (ART) program in Cameroon has reached one of the highest rate of coverage in Western and Central Africa (58% of the estimated eligible HIV-infected population in June 2008). OBJECTIVES: To assess the extent to which decentralized delivery of HIV care at the district level has contributed to increased access to ART. METHODS: Comparison of ART-treated and non-ART-treated in the sub-sample of medically eligible HIV-positive patients (n=2566) in the cross-sectional ANRS-EVAL survey was carried out among patients seeking HIV care in 14 hospitals at central level (Yaoundé, Douala and capitals of 8 provinces) and 13 at district levels. Logistic regressions and multivariate analysis were carried out to identify factors related to non-access to ART at both levels of care. RESULTS: Only 7% of eligible patients did not have access to ART. After adjustment for time since initial HIV diagnosis and CD4 counts (at initiation of treatment for those ART-treated and at time of survey for those who were not), younger and male patients, as well as those who only had a primary level education were less likely to be ART-treated at central but not at district level, whereas those who were unemployed were less likely to be treated at both levels. Patients were less likely to be treated in central hospitals with higher workload per medical staff member and absence of task shifting policy, and in district hospitals with non-availability of equipment for CD4 counts and larger size (150 beds or more). CONCLUSION: Main persisting barriers in access to ART in Cameroon are rather due to insufficient access to HIV testing and difficulties in patients' referral to ART delivery centers after HIV diagnosis, since the overwhelming majority of eligible patients already seeking HIV care had effective access. However, health systems strengthening (HSS) is still needed to overcome some remaining barriers in access to ART and to guarantee its long-term sustainability.


Subject(s)
Anti-Retroviral Agents/therapeutic use , HIV Infections/drug therapy , Health Services Accessibility/organization & administration , Healthcare Disparities/statistics & numerical data , Cameroon , Cross-Sectional Studies , Female , HIV Infections/therapy , Humans , Logistic Models , Male , Social Class , Surveys and Questionnaires
5.
Trop Med Int Health ; 13(12): 1470-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19000156

ABSTRACT

OBJECTIVE: To identify correlates of self-reported antiretroviral therapies (ART) interruptions among people living with HIV and AIDS (PLWHA) in Cameroon. METHODS: Analyses were based on data collected in the national survey EVAL (ANRS 12-116) among 533 ART-treated PLWHA in Yaoundé, the capital city of Cameroon, and its neighbourhood. Logistic regression models were used to identify factors associated with self-reported ART interruptions longer than two consecutive days during the previous 4 weeks. RESULTS: ART interruptions were reported by 68 patients (12.8%). After adjustment for gender, education and household income, characteristics independently associated with interruptions were pharmacy stock shortages [OR (95%CI):3.25 (1.78-5.90)], binge drinking [2.87 (1.39-5.91)] and the number of self-reported slimming symptoms [1.23 (1.02-1.48)]. CONCLUSION: In poor-resource settings where access to second and third-line regimens is still limited, food supply programs and interventions to minimise ART shortage may reduce the risk of ART interruptions.


Subject(s)
Anti-HIV Agents/administration & dosage , HIV Infections/drug therapy , Patient Compliance/statistics & numerical data , Acquired Immunodeficiency Syndrome/drug therapy , Adult , Alcohol Drinking , Anti-HIV Agents/supply & distribution , Anti-HIV Agents/therapeutic use , Cameroon , Cross-Sectional Studies , Drug Administration Schedule , Female , Food Supply , Health Surveys , Humans , Logistic Models , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...